Market News

Celgene (CELG) Shareholder Jd Capital Management Upped Stake; As Acadia Healthcare Company In (ACHC) Shares Rose, P2 Capital Partners Lifted Position by $42.96 Million

Claus Moller increased its stake in Acadia Healthcare Company In (ACHC) by 177.6% based on its latest 2017Q2 regulatory filing with the SEC. P2 Capital Partners Llc bought 876,659 shares as the company’s stock rose 2.28% with the market. The hedge fund run by Claus Moller held 1.37M shares of the health care company at the end of 2017Q2, valued at $67.67M, up from 493,627 at the end of the previous reported quarter. P2 Capital Partners Llc who had been investing in Acadia Healthcare Company In for a number of months, seems to be bullish on the $2.79B market cap company. The stock increased 0.92% or $0.29 during the last trading session, reaching $31.7. About 1.18M shares traded. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has declined 23.20% since December 15, 2016 and is downtrending. It has underperformed by 39.90% the S&P500.

Jd Capital Management Llc increased its stake in Celgene Corp (CELG) by 94.35% based on its latest 2017Q2 regulatory filing with the SEC. Jd Capital Management Llc bought 41,172 shares as the company’s stock declined 3.49% while stock markets rallied. The hedge fund held 84,811 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $11.01M, up from 43,639 at the end of the previous reported quarter. Jd Capital Management Llc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $86.06B market cap company. The stock increased 0.98% or $1.064 during the last trading session, reaching $109.304. About 3.83 million shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since December 15, 2016 and is uptrending. It has outperformed by 0.30% the S&P500.

Investors sentiment increased to 1.77 in Q2 2017. Its up 0.58, from 1.19 in 2017Q1. It is positive, as 32 investors sold ACHC shares while 52 reduced holdings. 56 funds opened positions while 93 raised stakes. 109.10 million shares or 4.03% more from 104.87 million shares in 2017Q1 were reported. Liberty Mutual Gp Asset Management holds 29,889 shares. Bnp Paribas Arbitrage holds 28,843 shares or 0% of its portfolio. Granahan Inv Mngmt Ma holds 0.28% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) for 61,825 shares. Panagora Asset holds 4,725 shares. Alliancebernstein Lp accumulated 65,453 shares. Frontier Cap Management Lc holds 2.33 million shares or 0.84% of its portfolio. Dimensional Fund Advsr Limited Partnership owns 1.49M shares. 19,900 are owned by Louisiana State Employees Retirement. Sg Americas Secs Ltd holds 0% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) or 5,663 shares. Pembroke Mgmt Limited reported 397,445 shares stake. Blair William Company Il invested in 12,869 shares. Airain invested in 0.1% or 47,338 shares. Archford Cap Strategies Ltd Liability Corp invested 0% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Ls Investment Advsr Limited Liability Corporation invested in 6,312 shares or 0.02% of the stock. Stifel Corp accumulated 100,432 shares or 0.02% of the stock.

Since June 16, 2017, it had 0 insider purchases, and 10 selling transactions for $270.94 million activity. Another trade for 984,075 shares valued at $49.88M was sold by WAUD REEVE B. Shares for $126.74M were sold by Gordon Christopher R on Monday, July 31. $152,791 worth of stock was sold by Schwieger Scott on Monday, July 31. The insider Howard Christopher L sold 53,713 shares worth $2.72 million. 80,000 shares valued at $4.06M were sold by Fincher Ronald Morgan on Tuesday, August 22. On Tuesday, August 22 the insider TURNER BRENT sold $10.45M.

Among 16 analysts covering Acadia Healthcare (NASDAQ:ACHC), 10 have Buy rating, 0 Sell and 6 Hold. Therefore 63% are positive. Acadia Healthcare had 45 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has “Hold” rating given on Wednesday, October 25 by Robert W. Baird. Jefferies maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on Wednesday, October 11 with “Buy” rating. Jefferies maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) rating on Tuesday, September 5. Jefferies has “Buy” rating and $60.0 target. UBS maintained it with “Buy” rating and $60 target in Monday, July 31 report. Deutsche Bank downgraded Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on Wednesday, October 25 to “Hold” rating. BMO Capital Markets maintained the shares of ACHC in report on Thursday, October 26 with “Outperform” rating. Mizuho maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) rating on Thursday, November 3. Mizuho has “Buy” rating and $45 target. The firm has “Buy” rating by Craig Hallum given on Thursday, October 26. Deutsche Bank maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) rating on Monday, July 31. Deutsche Bank has “Buy” rating and $60 target. The stock of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) earned “Buy” rating by Mizuho on Friday, April 29.

Among 33 analysts covering Celgene Corporation (NASDAQ:CELG), 21 have Buy rating, 2 Sell and 10 Hold. Therefore 64% are positive. Celgene Corporation had 114 analyst reports since July 21, 2015 according to SRatingsIntel. Oppenheimer maintained the stock with “Buy” rating in Wednesday, June 7 report. Canaccord Genuity maintained it with “Buy” rating and $15600 target in Thursday, July 27 report. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Leerink Swann on Wednesday, December 13. On Tuesday, September 1 the stock rating was initiated by Raymond James with “Strong-Buy”. The firm earned “Buy” rating on Thursday, June 1 by Mizuho. The company was initiated on Tuesday, November 8 by Mizuho. The rating was maintained by Wells Fargo with “Outperform” on Friday, December 4. On Friday, December 8 the stock rating was upgraded by Atlantic Securities to “Overweight”. The firm has “Hold” rating given on Friday, May 5 by Argus Research. Credit Suisse initiated Celgene Corporation (NASDAQ:CELG) on Wednesday, January 20 with “Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *